Analyst Ratings for Pandion Therapeutics (PAND)

PAND Rating Summary

  |   Expand Research on PAND
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 52%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/26/2021 Leerink Partners Geoffrey Porges Downgrade Market Perform
(Outperform)		 60.00
(24.00)		 25.63
(60.05)		 134.3% Details
2/25/2021 Morgan Stanley Vikram Purohit Downgrade Equalweight
(Overweight)		 N/A
(N/A)		 25.63
(60.05)		 134.3% Details